ID Q & A: Answers to Infectious Disease Questions Treating Spider Bites: Is Dapsone an Option?

Publication
Article
Consultant for PediatriciansConsultant for Pediatricians Vol 4 No 9
Volume 4
Issue 9

Some studies suggest that orally administered dapsone is effective for infections caused by spider bites (eg, brown recluse spiders) in dosages of 4 mg/kg/d for 3 days. Can dapsone be used in children and, if so, at what dosage?

Q: Some studies suggest that orally administered dapsone is effective for infections caused by spider bites (eg, brown recluse spiders) in dosages of 4 mg/kg/d for 3 days. Can dapsone be used in children and, if so, at what dosage?

----Ishkhan Babajanian, MD Santa Rosa, Calif

A:Treatments for brown recluse spider bites are controversial, and no conclusive test for envenomation is currently available. The majority of brown recluse spider bites heal without treatment within a few weeks or months.1,2 Patients with wounds that begin to show signs of tissue breakdown should receive prophylactic antibiotic therapy to prevent cellulitis.

Bites that become necrotic and show signs of edema within hours of the bite may respond to dapsone-- a drug thought to be effective if administered early in the course of disease.1 The beginning dosage I use for children is 1 mg/kg given every 24 hours. This dosage may be increased if there is no response in 72 hours. Dapsone is approved for use in children. Side effects are dose-related hemolysis, sore throat, pallor, and very rarely, agranulocytosis. Some of these side effects are severe, and for this reason the drug should only be used in moderate to severe cases.3

Corticosteroids have also been used to halt hemolysis with envenomation, to prevent kidney failure, and to reduce skin necrosis. When I treat patients, I use both dapsone and corticosteroids.

References:

REFERENCES:


1.Stibich AS, Schwartz RA. Brown recluse spider bite. eMedicine. Available at: http://www.emedicine.com/derm/topic598.htm. Accessed July 27, 2005.
2.Anderson PC. Spider bites in the United States.

Dermatol Clin.

1997;15:307-311.
3.Wendell RP. Brown recluse spiders: a review to help guide physicians in nonendemic areas.

South Med J.

2003;96:486-490.

Recent Videos
Wendy Ripple, MD
Wendy Ripple, MD
Lawrence Eichenfield, MD
Lawrence Eichenfield, MD | Image credit: KOL provided
FDA approves B-VEC to treat dystrophic epidermolysis bullosa patients 6 months and older | Image Credit: bankrx - Image Credit: bankrx - stock.adobe.com.
Related Content
© 2024 MJH Life Sciences

All rights reserved.